R
Ryan S. Noyce
Researcher at University of Alberta
Publications - 36
Citations - 2212
Ryan S. Noyce is an academic researcher from University of Alberta. The author has contributed to research in topics: Virus & Medicine. The author has an hindex of 18, co-authored 28 publications receiving 1876 citations. Previous affiliations of Ryan S. Noyce include Halifax & McMaster University.
Papers
More filters
Journal ArticleDOI
Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
Ryan S. Noyce,Daniel G. Bondre,Daniel G. Bondre,Michael N. Ha,Michael N. Ha,Liang Tzung Lin,Liang Tzung Lin,Gary Sisson,Gary Sisson,Ming-Sound Tsao,Ming-Sound Tsao,Christopher D. Richardson,Christopher D. Richardson +12 more
TL;DR: It is demonstrated that wild type measles virus infects primary airway epithelial cells grown in fetal calf serum and many adenocarcinoma cell lines of the lung, breast, and colon and several strains of measles virus were shown to use PVRL4 as a receptor.
Journal ArticleDOI
The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes
TL;DR: It is demonstrated that HSV-1 modifies the IRF3 pathway in a manner different from that of the small RNA viruses most commonly studied, and that the RING finger domain of ICP0 is essential for this activity.
Journal ArticleDOI
Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication
TL;DR: It is shown that the entry of enveloped virus particles from diverse virus families elicits a similar innate response to IRF3, but not IRF1, IRF7, or IRF9, and that subsequent virus replication results in posttranslational modification of IRf3, such as hyperphosphorylation, depending on the nature of the incoming virus.
Journal ArticleDOI
Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments
TL;DR: This work believes this is the first complete synthesis of a poxvirus using synthetic biology approaches and supports further development of scHPXV as a novel replication-proficient smallpox vaccine.
Journal ArticleDOI
Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread
Liang Tzung Lin,Ting Ying Chen,Chueh Yao Chung,Ryan S. Noyce,T. Bruce Grindley,Craig McCormick,Ta Chen Lin,Guey Horng Wang,Chun Ching Lin,Christopher D. Richardson +9 more
TL;DR: It is suggested that the hydrolyzable tannins CHLA and PUG may be useful as competitors for glycosaminoglycans in the management of HSV-1 infections and that they may help reduce the risk for development of viral drug resistance during therapy with nucleoside analogues.